W Rudy
Overview
Explore the profile of W Rudy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
1105
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Linnebacher M, Gebert J, Rudy W, Woerner S, Yuan Y, Bork P, et al.
Int J Cancer
. 2001 Jun;
93(1):6-11.
PMID: 11391614
Microsatellite instability (MSI) caused by defective DNA mismatch repair (MMR) is a hallmark of hereditary nonpolyposis colorectal cancers (HNPCC) but also occurs in about 15% of sporadic tumors. If instability...
2.
Klaes R, Friedrich T, Spitkovsky D, Ridder R, Rudy W, Petry U, et al.
Int J Cancer
. 2001 Apr;
92(2):276-84.
PMID: 11291057
Cytological screening for cervical cancer or its precursors using Papanicolaou's smear test (Pap test) has been highly efficient to reduce the morbidity and mortality of cervical cancer. However, evaluation of...
3.
Meyer G, Batrla R, Rudy W, Meuer S, Wallwiener D, Guckel B, et al.
Cancer Gene Ther
. 1999 Jun;
6(3):282-8.
PMID: 10359214
Allogeneic human histocompatibility leukocyte antigen (HLA)-matched tumor cell lines that have been made immunogenic by the transfer of genes encoding for costimulatory molecules such as CD80 are considered to be...
4.
Guckel B, Meyer G, Rudy W, Batrla R, Meuer S, Bastert G, et al.
Cancer Gene Ther
. 1999 Jun;
6(3):228-37.
PMID: 10359208
One possible reason for the poor immunogenicity of tumors is the induction of peripheral tolerance by tumor cells that fail to deliver costimulatory signals. Furthermore, T cells stimulated with wild-type...
5.
Meyer G, Moebius U, Rudy W, Batrla R, Meuer S, Wallwiener D, et al.
Adv Exp Med Biol
. 1999 Feb;
451:195-202.
PMID: 10026872
No abstract available.
6.
Lindauer M, Rudy W, Guckel B, Doeberitz M, Meuer S, Moebius U
Immunology
. 1998 Jun;
93(3):390-7.
PMID: 9640250
Colorectal cancer is considered a non-immunogenic malignany. One strategy to augment the immunogenicity of such tumours is represented by the expression of costimulatory molecules by gene transfer. Using transfected variants...
7.
Meuer S, Guckel B, Lindauer M, Rudy W, Moebius U
Recent Results Cancer Res
. 1997 Sep;
144:78-85.
PMID: 9304710
No abstract available.
8.
Rudy W, Guckel B, Siebels M, Lindauer M, Meuer S, Moebius U
Int Immunol
. 1997 Jun;
9(6):853-60.
PMID: 9199968
Introduction of co-stimulatory molecules like CD80 and CD86 represents a means to augment the immunogenicity of tumor cells and to induce immune responses directed at tumor antigens. Here we compared...
9.
Sleeman J, Rudy W, Hofmann M, Moll J, Herrlich P, Ponta H
J Cell Biol
. 1996 Nov;
135(4):1139-50.
PMID: 8922392
Cell contact with the extracellular matrix component hyaluronic acid (HA) plays an important role in many developmental, physiological, and pathological processes, although the regulation of this contact is poorly understood....
10.
Sleeman J, Arming S, Moll J, Hekele A, Rudy W, SHERMAN L, et al.
Cancer Res
. 1996 Jul;
56(13):3134-41.
PMID: 8674073
Several studies have demonstrated a correlation between the expression of CD44 variant isoforms and the ability of tumor cells to metastasize. The CD44 proteins carry amino acid sequence motifs that...